Found: 7
Select item for more details and to access through your institution.
Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
- Published in:
- Acta Neuropathologica, 2021, v. 142, n. 2, p. 339, doi. 10.1007/s00401-021-02327-x
- By:
- Publication type:
- Article
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01363-2
- By:
- Publication type:
- Article
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF<sup>V600E</sup>/TERT promoter double-mutated glioma.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0775-6
- By:
- Publication type:
- Article
p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3205, doi. 10.3390/cancers12113205
- By:
- Publication type:
- Article
Novel Insights into Diagnosis, Biology, and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 292, doi. 10.3390/jpm11040292
- By:
- Publication type:
- Article
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 9, p. 1183, doi. 10.1093/neuonc/nox027
- By:
- Publication type:
- Article
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 2, p. 238, doi. 10.3390/pharmaceutics14020238
- By:
- Publication type:
- Article